Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga PSMA-11 PET/CT for Diagnosis of Primary and Metastatic Prostate Cancer
NCT04179968Phase 2Completed
- Start
- Jan 2020
- Primary completion
- Sep 2021
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga-68 gozetotide in prostate cancer (PCa). Started Jan 2020; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04179968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04179968.